tetano
Editor, Senior Moderator
Annu Rev Biomed Eng
. 2022 Feb 1.
doi: 10.1146/annurev-bioeng-110220-031722. Online ahead of print.
Current Developments and Challenges of mRNA Vaccines
Jinjin Chen[SUP] 1 [/SUP], Jianzhu Chen[SUP] 2 [/SUP], Qiaobing Xu[SUP] 1 [/SUP]
Affiliations
Abstract
mRNA vaccines have brought about a great revolution in the vaccine fields owing to their simplicity and adaptability in antigen design, potential to induce both humoral and cell-mediated immune responses and demonstrated high efficacy, and rapid and low-cost production by using the same manufacturing platform for different mRNA vaccines. Multiple mRNA vaccines have been investigated for both infectious diseases and cancers, showing significant superiority to other types of vaccines. Although great success of mRNA vaccines has been achieved in the control of the coronavirus disease 2019 pandemic, there are still multiple challenges for the future development of mRNA vaccines. In this review, the most recent developments of mRNA vaccines against both infectious diseases and cancers are summarized for an overview of this field. Moreover, the challenges are also discussed on the basis of these developments. Expected final online publication date for the Annual Review of Biomedical Engineering, Volume 24 is June 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
. 2022 Feb 1.
doi: 10.1146/annurev-bioeng-110220-031722. Online ahead of print.
Current Developments and Challenges of mRNA Vaccines
Jinjin Chen[SUP] 1 [/SUP], Jianzhu Chen[SUP] 2 [/SUP], Qiaobing Xu[SUP] 1 [/SUP]
Affiliations
- PMID: 35231177
- DOI: 10.1146/annurev-bioeng-110220-031722
Abstract
mRNA vaccines have brought about a great revolution in the vaccine fields owing to their simplicity and adaptability in antigen design, potential to induce both humoral and cell-mediated immune responses and demonstrated high efficacy, and rapid and low-cost production by using the same manufacturing platform for different mRNA vaccines. Multiple mRNA vaccines have been investigated for both infectious diseases and cancers, showing significant superiority to other types of vaccines. Although great success of mRNA vaccines has been achieved in the control of the coronavirus disease 2019 pandemic, there are still multiple challenges for the future development of mRNA vaccines. In this review, the most recent developments of mRNA vaccines against both infectious diseases and cancers are summarized for an overview of this field. Moreover, the challenges are also discussed on the basis of these developments. Expected final online publication date for the Annual Review of Biomedical Engineering, Volume 24 is June 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.